OBJECTIVE: HIV infection is associated with coagulation abnormalities and significantly increased risk of venous thrombosis. It has been shown that higher plasma levels of coagulation and inflammatory biomarkers predicted mortality in HIV. We investigated the relationship between venous thrombosis and HIV-related characteristics, traditional risk factors of hypercoagulability, and pre-event levels of biomarkers. DESIGN: A retrospective case-control study of 23 HIV-infected individuals who experienced an incident venous thromboembolic event while enrolled in National Institutes of Health studies from 1995 to 2010 and 69 age-matched and sex-matched HIV-infected individuals without known venous thromboembolism (VTE). METHODS: Biomarkers of inflammation, endothelial dysfunction, coagulation, tissue fibrosis, and cytomegalovirus (CMV) reactivation were assessed by ELISA-based assays and PCR using plasma obtained prior to the event. RESULTS: VTE events were related to nadir CD4 cell count, lifetime history of multiple opportunistic infections, CMV disease, CMV viremia, immunological AIDS, active infection, and provocation (i.e., recent hospitalization, surgery, or trauma). VTE events were independently associated with increased plasma levels of P-selectin (P = 0.002), D-dimer (P = 0.01), and hyaluronic acid (P = 0.009) in a multivariate analysis. No significant differences in antiretroviral or interleukin-2 exposures, plasma HIV viremia, or other traditional risk factors were observed. CONCLUSION: Severe immunodeficiency, active infection, and provocation are associated with venous thromboembolic disease in HIV. Biomarkers of endothelial dysfunction, coagulation, and tissue fibrosis may help identify HIV-infected patients at elevated risk of VTE.
OBJECTIVE:HIV infection is associated with coagulation abnormalities and significantly increased risk of venous thrombosis. It has been shown that higher plasma levels of coagulation and inflammatory biomarkers predicted mortality in HIV. We investigated the relationship between venous thrombosis and HIV-related characteristics, traditional risk factors of hypercoagulability, and pre-event levels of biomarkers. DESIGN: A retrospective case-control study of 23 HIV-infected individuals who experienced an incident venous thromboembolic event while enrolled in National Institutes of Health studies from 1995 to 2010 and 69 age-matched and sex-matched HIV-infected individuals without known venous thromboembolism (VTE). METHODS: Biomarkers of inflammation, endothelial dysfunction, coagulation, tissue fibrosis, and cytomegalovirus (CMV) reactivation were assessed by ELISA-based assays and PCR using plasma obtained prior to the event. RESULTS:VTE events were related to nadir CD4 cell count, lifetime history of multiple opportunistic infections, CMV disease, CMV viremia, immunological AIDS, active infection, and provocation (i.e., recent hospitalization, surgery, or trauma). VTE events were independently associated with increased plasma levels of P-selectin (P = 0.002), D-dimer (P = 0.01), and hyaluronic acid (P = 0.009) in a multivariate analysis. No significant differences in antiretroviral or interleukin-2 exposures, plasma HIV viremia, or other traditional risk factors were observed. CONCLUSION:Severe immunodeficiency, active infection, and provocation are associated with venous thromboembolic disease in HIV. Biomarkers of endothelial dysfunction, coagulation, and tissue fibrosis may help identify HIV-infectedpatients at elevated risk of VTE.
Authors: Claudette S Satchell; Aoife G Cotter; Eileen F O'Connor; Aaron J Peace; Anthony F Tedesco; Andrew Clare; John S Lambert; Gerard J Sheehan; Dermot Kenny; Patrick W G Mallon Journal: AIDS Date: 2010-03-13 Impact factor: 4.177
Authors: A Celi; G Pellegrini; R Lorenzet; A De Blasi; N Ready; B C Furie; B Furie Journal: Proc Natl Acad Sci U S A Date: 1994-09-13 Impact factor: 11.205
Authors: R Mehrian; F P Quismorio; G Strassmann; M M Stimmler; D A Horwitz; R C Kitridou; W J Gauderman; J Morrison; C Brautbar; C O Jacob Journal: Arthritis Rheum Date: 1998-04
Authors: S K Klein; E J Slim; M D de Kruif; T T Keller; H ten Cate; E C M van Gorp; D P M Brandjes Journal: Neth J Med Date: 2005-04 Impact factor: 1.422
Authors: Edison R Parise; Ana C Oliveira; Cláudio Figueiredo-Mendes; Valéria Lanzoni; João Martins; Helena Nader; Maria L Ferraz Journal: Liver Int Date: 2006-11 Impact factor: 5.828
Authors: M Cushman; R N Lemaitre; L H Kuller; B M Psaty; E M Macy; A R Sharrett; R P Tracy Journal: Arterioscler Thromb Vasc Biol Date: 1999-03 Impact factor: 8.311
Authors: Gabriela F de Larrañaga; Andrea R Bocassi; Liliana M Puga; Beatriz S Alonso; Jorge A Benetucci Journal: Thromb Res Date: 2003-05-01 Impact factor: 3.944
Authors: Stephen Burgess; Simon G Thompson; S Burgess; S G Thompson; G Andrews; N J Samani; A Hall; P Whincup; R Morris; D A Lawlor; G Davey Smith; N Timpson; S Ebrahim; Y Ben-Shlomo; G Davey Smith; N Timpson; M Brown; S Ricketts; M Sandhu; A Reiner; B Psaty; L Lange; M Cushman; J Hung; P Thompson; J Beilby; N Warrington; L J Palmer; B G Nordestgaard; A Tybjaerg-Hansen; J Zacho; C Wu; G Lowe; I Tzoulaki; M Kumari; M Sandhu; J F Yamamoto; B Chiodini; M Franzosi; G J Hankey; K Jamrozik; L Palmer; E Rimm; J Pai; B Psaty; S Heckbert; J Bis; S Anand; J Engert; R Collins; R Clarke; O Melander; G Berglund; P Ladenvall; L Johansson; J-H Jansson; G Hallmans; A Hingorani; S Humphries; E Rimm; J Manson; J Pai; H Watkins; R Clarke; J Hopewell; D Saleheen; R Frossard; J Danesh; N Sattar; M Robertson; J Shepherd; E Schaefer; A Hofman; J C M Witteman; I Kardys; Y Ben-Shlomo; G Davey Smith; N Timpson; U de Faire; A Bennet; N Sattar; I Ford; C Packard; M Kumari; J Manson; Debbie A Lawlor; George Davey Smith; S Anand; R Collins; J P Casas; J Danesh; G Davey Smith; M Franzosi; A Hingorani; D A Lawlor; J Manson; B G Nordestgaard; N J Samani; M Sandhu; L Smeeth; F Wensley; S Anand; J Bowden; S Burgess; J P Casas; E Di Angelantonio; J Engert; P Gao; T Shah; L Smeeth; S G Thompson; C Verzilli; M Walker; J Whittaker; A Hingorani; J Danesh Journal: Stat Med Date: 2010-05-30 Impact factor: 2.373
Authors: David A Zidar; Steven Juchnowski; Brian Ferrari; Brian Clagett; Heather A Pilch-Cooper; Shawn Rose; Benigno Rodriguez; Grace A McComsey; Scott F Sieg; Nehal N Mehta; Michael M Lederman; Nicholas T Funderburg Journal: J Acquir Immune Defic Syndr Date: 2015-06-01 Impact factor: 3.731
Authors: Irini Sereti; Shelly J Krebs; Nittaya Phanuphak; James L Fletcher; Bonnie Slike; Suteeraporn Pinyakorn; Robert J O'Connell; Adam Rupert; Nicolas Chomont; Victor Valcour; Jerome H Kim; Merlin L Robb; Nelson L Michael; Daniel C Douek; Jintanat Ananworanich; Netanya S Utay Journal: Clin Infect Dis Date: 2016-10-12 Impact factor: 9.079
Authors: Eleanor M P Wilson; Amrit Singh; Katherine Huppler Hullsiek; Dave Gibson; W Keith Henry; Ken Lichtenstein; Nur F Önen; Erna Kojic; Pragna Patel; John T Brooks; Irini Sereti; Jason V Baker Journal: J Infect Dis Date: 2014-05-09 Impact factor: 5.226
Authors: Nicholas T Funderburg; David A Zidar; Carey Shive; Anthony Lioi; Joseph Mudd; Laura W Musselwhite; Daniel I Simon; Marco A Costa; Benigno Rodriguez; Scott F Sieg; Michael M Lederman Journal: Blood Date: 2012-10-11 Impact factor: 22.113